Management of Coagulopathy in Postpartum Hemorrhage.

Published

Journal Article (Review)

The purpose of this article is to review the use of blood products and hemostatic agents in the management of coagulopathy at the time of postpartum hemorrhage. Blood product administration strategies are broadly reviewed, including the role of the blood bank, the role of massive transfusion protocols, the role of laboratory monitoring, and the role of anesthesia management. Aspects of patient blood management are discussed. The concept refers to an evidence-based, comprehensive, multidisciplinary approach to optimizing the care of patients who might need transfusion and includes measures to avoid or minimize transfusion such as preoperative anemia management, cell salvage, and the use of hemostatic medication to reduce bleeding. The contributions of individual blood components-red blood cells, plasma, cryoprecipitate, and platelets-are described. Current data regarding the complementary role of hemostatic agents-antifibrinolytic agents and clotting factor concentrates-are presented. Two developments in blood component pathogen reduction are introduced.

Full Text

Duke Authors

Cited Authors

  • James, AH; Grotegut, C; Ahmadzia, H; Peterson-Layne, C; Lockhart, E

Published Date

  • October 2016

Published In

Volume / Issue

  • 42 / 7

Start / End Page

  • 724 - 731

PubMed ID

  • 27699730

Pubmed Central ID

  • 27699730

Electronic International Standard Serial Number (EISSN)

  • 1098-9064

Digital Object Identifier (DOI)

  • 10.1055/s-0036-1593417

Language

  • eng

Conference Location

  • United States